Reyhane Ebrahimi

Reyhane Ebrahimi

Auto-generated profile, based on publicly available information

Reyhane Ebrahimi

Department of Clinical Biochemistry, School of Medicine Tehran University of Medical Sciences Tehran Iran

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2019 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
AAAmirsaeed S. Aghabozorgi
Amirsaeed S. Aghabozorgi
NANajmeh Ahangari
Najmeh Ahangari
TETasnim E. Eftekhaari
Tasnim E. Eftekhaari
PTParia N. Torbati
Paria N. Torbati
ABAlireza Bahiraee
Alireza Bahiraee
APAlireza Pasdar
Alireza Pasdar

2 January 2020 in Critical Reviews in Clinical Laboratory Sciences
Verified
Journal Article
Closed access
SESolaleh Emamgholipour
Solaleh Emamgholipour
REReyhane Ebrahimi
Reyhane Ebrahimi
ABAlireza Bahiraee
Alireza Bahiraee
FNFarshad Niazpour
Farshad Niazpour
RMReza Meshkani
Reza Meshkani
Insulin resistance is associated with an increased risk of several metabolic disorders including type 2 diabetes, hypertension and cardiovascular diseases. Advances over the last decade have expanded our understanding of the molecular mechanisms underlying insulin resistance; however, many details of the mechanisms causing insulin resistance remain unknown. Recently, attention has shifted toward the role of epigenetics in insulin resistance. In this regard, acetylation of the histone tails has been widely investigated for its role in influencing both metabolic and mitogenic cascades of insulin signaling. More specifically, histone acetyltransferases and histone deacetylases, as major modulators of chromatin accessibility and gene expression, have been studied to determine a possible interconnectivity between the special effects of lysine acetylation status and tyrosine phosphorylation networks on the target proteins of downstream pathways involved in both metabolic and mitogenic cascades of insulin signaling. There is accumulating evidence for the post-translational modification effects of IGFR, InsR, IRS1/2, PI3K, Akt, GLUT4, FoxO, PGC-1α, PPAR, AMPK and MAPKs on insulin resistance and glucose homeostasis. In this paper, we review the importance of acetylation of these factors in the regulation of insulin signaling and glucose metabolism, with a primary focus on the target proteins of downstream signaling of insulin. We also provide an update on the interplay between epigenetic modification and the cellular genome in the context of insulin signaling and describe the possible effect of the environment on this epigenetic regulation.

17 July 2021 in Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity
Verified
Journal Article
Closed access
PDF file
HYHabib Yarizadeh
Habib Yarizadeh
LSleila setayesh
leila setayesh
NMNazanin Majidi
Nazanin Majidi
NRNiloufar Rasaei
Niloufar Rasaei
SMSanaz Mehranfar
Sanaz Mehranfar
KMKhadijeh Mirzaei
Khadijeh Mirzaei

17 September 2021 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
STSadra Samavarchi Tehrani
Sadra Samavarchi Tehrani
REReyhane Ebrahimi
Reyhane Ebrahimi
AAAtiyeh Al-E-Ahmad
Atiyeh Al-E-Ahmad
GPGhodratollah Panahi
Ghodratollah Panahi
RMReza Meshkani
Reza Meshkani
HPHadi Parsian
Hadi Parsian
Neurological disorders (NDs) comprise a broad range of diseases affecting both central and peripheral nervous systems. These complex multifactorial diseases have a high rate of mortality all over the world, particularly in aged people. Today, new evidence drove our attention to the notable role of noncoding RNAs (ncRNAs) in the progression of NDs. Remarkably, recent studies showed that there are close communication networks among RNA transcripts such as mRNAs, long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), and pseudogenes for regulating each other’s expression through competing for shared sequences in microRNAs (miRs). This concept is a new area of ongoing research recognized as competing endogenous RNA (ceRNA) hypothesis. CeRNAs are novel regulatory molecules in a wide range of biological stages and pathological contexts. Indeed, the disruption of ceRNA networks (ceRNETs) may affect neural development genes and induce neuropathological changes leading to the development of NDs. Because of this, identifying the correlation of ceRNETs with NDs will open a new window for expanding our knowledge about this field of science, as well as creating novel roads for developing specific diagnostic biomarkers for NDs management. Owing to these unique features, exploring the exact role of ceRNAs is a hot topic in NDs investigations. Hence, in this review, we will summarize the evidence supporting ceRNETs in the regulation of NDs-related gene expression.

5 January 2022 in Journal of Physiology and Biochemistry
Verified
Journal Article
Closed access
PDF file
REReyhane Ebrahimi
Reyhane Ebrahimi
PPParvin Pasalar
Parvin Pasalar
HSHajar Shokri
Hajar Shokri
MSMaryam Shabani
Maryam Shabani
SESolaleh Emamgholipour
Solaleh Emamgholipour

1 November 2021 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
REReyhane Ebrahimi
Reyhane Ebrahimi
AGAbolfazl Golestani
Abolfazl Golestani